TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,770,000 | -37.5% | 100,000 | -12.9% | 0.01% | -40.0% |
| Q3 2021 | $7,628,000 | -51.1% | 114,822 | -42.6% | 0.02% | -51.6% |
| Q2 2021 | $15,604,000 | +65.0% | 200,000 | +100.0% | 0.03% | +63.2% |
| Q1 2021 | $9,459,000 | -55.6% | 100,000 | -42.9% | 0.02% | -58.7% |
| Q4 2020 | $21,324,000 | +22.0% | 175,000 | -12.5% | 0.05% | +4.5% |
| Q3 2020 | $17,472,000 | +54.6% | 200,000 | +14.3% | 0.04% | +51.7% |
| Q2 2020 | $11,303,000 | +102.5% | 175,000 | +40.0% | 0.03% | +70.6% |
| Q1 2020 | $5,583,000 | +258.6% | 125,000 | +400.0% | 0.02% | +325.0% |
| Q4 2019 | $1,557,000 | -79.3% | 25,000 | -87.5% | 0.00% | -77.8% |
| Q3 2019 | $7,520,000 | -7.6% | 200,000 | 0.0% | 0.02% | -10.0% |
| Q2 2019 | $8,140,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |